Roivant Sciences Ltd. Common Shares
Here’s whether Roivant Sciences Ltd. Common Shares (ROIV) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.39% over 10 days); RSI 57 — healthy momentum range; strong 1-year return of +208.1%; 3-month momentum positive (+23.6%); rising volume confirms the move (1.20x 30d avg). Currently 2.2% off its 52-week high. Score: +8/7.
ROIV is in a confirmed uptrend, trading above both its 50-day ($33.67) and 200-day ($27.31) moving averages. An RSI of 57.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +208.1% compares to +20.4% for SPY (beat the market by 187.7%).